Jiangsu Hengrui Medicine
600276.SS
#489
Rank
ยฃ33.33 B
Marketcap
ยฃ5.23
Share price
-1.55%
Change (1 day)
-0.58%
Change (1 year)
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics

EPS for Jiangsu Hengrui Medicine (600276.SS)

EPS in 2023 (TTM): ยฃ0.07546

According to Jiangsu Hengrui Medicine 's latest financial reports the company's current EPS (TTM) is ยฃ0.07203. In 2022 the company made an earnings per share (EPS) of ยฃ0.07182 a decrease over its 2021 EPS that were of ยฃ0.08663.

EPS history for Jiangsu Hengrui Medicine from 2002 to 2023

Annual EPS

Year EPS Change
2023 (TTM)ยฃ0.075465.07%
2022ยฃ0.07182-17.1%
2021ยฃ0.08663-24.44%
2020ยฃ0.1120.3%
2019ยฃ0.0953025.58%
2018ยฃ0.0758927.55%
2017ยฃ0.0595021.64%
2016ยฃ0.0489113.57%
2015ยฃ0.0430739.86%
2014ยฃ0.0307921.33%
2013ยฃ0.0253817.7%
2012ยฃ0.0215625.56%
2011ยฃ0.0171726.22%
2010ยฃ0.0136110.3%
2009ยฃ0.0123457.92%
2008ยฃ0.00781111.06%
2007ยฃ0.00703385.81%
2006ยฃ0.00378587.94%
2005ยฃ0.00201433.97%
2004ยฃ0.00150329.78%
2003ยฃ0.00115819.78%
2002ยฃ0.0009670